<VariationArchive VariationID="31155" VariationName="NM_031448.6(C19orf12):c.171_181del (p.Gly58fs)" VariationType="Deletion" Accession="VCV000031155" Version="29" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-15" DateCreated="2015-03-24" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="40112" VariationID="31155">
      <GeneList>
        <Gene Symbol="C19orf12" FullName="chromosome 19 open reading frame 12" GeneID="83636" HGNC_ID="HGNC:25443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29698886" stop="29715789" display_start="29698886" display_stop="29715789" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30189792" stop="30206695" display_start="30189792" display_stop="30206695" Strand="-" />
          </Location>
          <OMIM>614297</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_031448.6(C19orf12):c.171_181del (p.Gly58fs)</Name>
      <CanonicalSPDI>NC_000019.10:29702956:ACAGCCCCCCGACAGCCCCCC:ACAGCCCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29702957" stop="29702967" display_start="29702957" display_stop="29702967" variantLength="11" positionVCF="29702956" referenceAlleleVCF="AACAGCCCCCCG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30193864" stop="30193874" display_start="30193864" display_stop="30193874" variantLength="11" positionVCF="30193863" referenceAlleleVCF="AACAGCCCCCCG" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>C19ORF12, 11-BP DEL, NT204</Name>
      </OtherNameList>
      <ProteinChange>G58fs</ProteinChange>
      <ProteinChange>G69fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.29702967_29702977del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.29702967_29702977del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.30193874_30193884del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.30193874_30193884del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031970.2" sequenceAccession="NG_031970" sequenceVersion="2" change="g.17823_17833del">
            <Expression>NG_031970.2:g.17823_17833del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031726.4" sequenceAccession="NM_001031726" sequenceVersion="4" change="c.171_181del">
            <Expression>NM_001031726.4:c.171_181del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001026896.3" sequenceAccession="NP_001026896" sequenceVersion="3" change="p.Gly58fs">
            <Expression>NP_001026896.3:p.Gly58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256046.3" sequenceAccession="NM_001256046" sequenceVersion="3" change="c.171_181del">
            <Expression>NM_001256046.3:c.171_181del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242975.1" sequenceAccession="NP_001242975" sequenceVersion="1" change="p.Gly58fs">
            <Expression>NP_001242975.1:p.Gly58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256047.2" sequenceAccession="NM_001256047" sequenceVersion="2" change="c.171_181del">
            <Expression>NM_001256047.2:c.171_181del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242976.1" sequenceAccession="NP_001242976" sequenceVersion="1" change="p.Gly58fs">
            <Expression>NP_001242976.1:p.Gly58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282929.1" sequenceAccession="NM_001282929" sequenceVersion="1" change="c.-22_-12del">
            <Expression>NM_001282929.1:c.-22_-12del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282930.3" sequenceAccession="NM_001282930" sequenceVersion="3" change="c.-22_-12del">
            <Expression>NM_001282930.3:c.-22_-12del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282931.3" sequenceAccession="NM_001282931" sequenceVersion="3" change="c.-22_-12del">
            <Expression>NM_001282931.3:c.-22_-12del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031448.6" sequenceAccession="NM_031448" sequenceVersion="6" change="c.171_181del" MANESelect="true">
            <Expression>NM_031448.6:c.171_181del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_113636.2" sequenceAccession="NP_113636" sequenceVersion="2" change="p.Gly58fs">
            <Expression>NP_113636.2:p.Gly58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031726.3" sequenceAccession="NM_001031726" sequenceVersion="3" change="c.204_214del11">
            <Expression>NM_001031726.3:c.204_214del11</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031726.4" sequenceAccession="NM_001031726" sequenceVersion="4" change="c.171_181del11">
            <Expression>NM_001031726.4:c.171_181del11</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA345635" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614297.0001" DB="OMIM" />
        <XRef Type="rs" ID="515726204" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031448.6(C19orf12):c.171_181del (p.Gly58fs) AND Neurodegeneration with brain iron accumulation 4" Accession="RCV000024151" Version="10">
        <ClassifiedConditionList TraitSetID="7628">
          <ClassifiedCondition DB="MedGen" ID="C3280371">Neurodegeneration with brain iron accumulation 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-01-15" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031448.6(C19orf12):c.171_181del (p.Gly58fs) AND Hereditary spastic paraplegia 43" Accession="RCV001044832" Version="7">
        <ClassifiedConditionList TraitSetID="12251">
          <ClassifiedCondition DB="MedGen" ID="C2680446">Hereditary spastic paraplegia 43</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-24" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031448.6(C19orf12):c.171_181del (p.Gly58fs) AND not provided" Accession="RCV001781311" Version="14">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-12-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031448.6(C19orf12):c.171_181del (p.Gly58fs) AND Neurodegeneration with brain iron accumulation" Accession="RCV003155040" Version="3">
        <ClassifiedConditionList TraitSetID="9400">
          <ClassifiedCondition DB="MedGen" ID="C2931845">Neurodegeneration with brain iron accumulation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031448.6(C19orf12):c.171_181del (p.Gly58fs) AND C19orf12-related disorder" Accession="RCV003904862" Version="1">
        <ClassifiedConditionList TraitSetID="93967">
          <ClassifiedCondition>C19orf12-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-24" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2015-03-24" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21981780</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23269600</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23436634</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28641177</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30392167</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31087512</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33607528</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">24575447</ID>
          <ID Source="BookShelf">NBK185329</ID>
        </Citation>
        <DescriptionHistory Dated="2022-01-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="7628" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16586" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation 4</ElementValue>
                <XRef ID="MONDO:0013674" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA4</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MPAN</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520058" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529414" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508834" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512825" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mitochondrial membrane protein-associated neurodegeneration (MPAN) is characterized initially by gait changes followed by progressive spastic paresis, progressive dystonia (which may be limited to the hands and feet or more generalized), neuropsychiatric abnormalities (emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity), and cognitive decline. Additional early findings can include dysphagia, dysarthria, optic atrophy, axonal neuropathy, parkinsonism, and bowel/bladder incontinence. Survival is usually well into adulthood. End-stage disease is characterized by severe dementia, spasticity, dystonia, and parkinsonism.</Attribute>
                <XRef ID="NBK185329" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12569" />
                <XRef ID="12569" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24575447</ID>
                <ID Source="BookShelf">NBK185329</ID>
              </Citation>
              <XRef ID="289560" DB="Orphanet" />
              <XRef ID="C3280371" DB="MedGen" />
              <XRef ID="MONDO:0013674" DB="MONDO" />
              <XRef Type="MIM" ID="614298" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 43, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 43</ElementValue>
                <XRef ID="MONDO:0014024" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPG43</ElementValue>
                <XRef Type="MIM" ID="615043" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17473" />
                <XRef ID="17473" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="320370" DB="Orphanet" />
              <XRef ID="C2680446" DB="MedGen" />
              <XRef ID="MONDO:0014024" DB="MONDO" />
              <XRef Type="MIM" ID="615043" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="93967" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="73547" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">C19orf12-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">C19orf12-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9400" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9539" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation</ElementValue>
                <XRef ID="156905" DB="GeneTests" />
                <XRef ID="MONDO:0018307" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS234200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11899" />
                <XRef ID="11899" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review">
                <ID Source="PubMed">22704258</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="385" DB="Orphanet" />
              <XRef ID="C2931845" DB="MedGen" />
              <XRef ID="MONDO:0018307" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS234200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50698" SubmissionDate="2019-07-19" DateLastUpdated="2019-07-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614297.0001_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL RECESSIVE" title="C19ORF12, 11-BP DEL, NT204_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000045442" DateUpdated="2019-07-22" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-01-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 13 of 24 Polish probands with neurodegeneration with brain iron accumulation-4 (NBIA4; 614298), Hartig et al. (2011) identified a homozygous 11-bp deletion (c.204_214del, NM_001031726.2) in the C19ORF12 gene, resulting in a frameshift and premature stop codon (Gly69ArgfsTer10) leading to a predicted truncation of more than 50% of the protein. Immunoblot analysis showed absence of the protein in patient fibroblasts, consistent with a loss of function. Haplotype analysis suggested a founder effect, with the mutation occurring at least 50 to 100 generations earlier. The mutation was not found in 750 control chromosomes. Three additional probands were compound heterozygous for the 11-bp deletion and another missense mutation in the C19ORF12 gene (see, e.g., T11M, 614297.0002). The mean age at onset was 9.2 years (range, 4 to 20), but most presented before age 11. The most common presenting symptom was gait or speech difficulty, followed by extrapyramidal signs, oromandibular and generalized dystonia, and parkinsonism. Most had progressive involvement of the corticospinal tract, with spasticity, hyperreflexia, and extensor plantar responses. Other features included motor axonal neuropathy, optic atrophy, and cognitive decline. Brain MRI showed hypointensities in the globus pallidus.</Attribute>
              <Citation>
                <ID Source="PubMed">21981780</ID>
              </Citation>
              <XRef DB="OMIM" ID="614298" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Hogarth et al. (2013) identified the homozygous 11-bp deletion in 3 unrelated patients with NBIA4 of Bosnian, Ukrainian, and mixed Eastern European ancestry, respectively. Four additional NBIA4 patients, including a pair of sibs, were compound heterozygous for the 11-bp deletion and another pathogenic C19ORF12 mutation. All of these patients were of Polish or other Eastern European ancestry.</Attribute>
              <Citation>
                <ID Source="PubMed">23269600</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19ORF12" />
          </GeneList>
          <Name>C19ORF12, 11-BP DEL, NT204</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11-BP DEL, NT204</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614297.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4032643" SubmissionDate="2022-01-11" DateLastUpdated="2022-01-15" DateCreated="2022-01-15">
        <ClinVarSubmissionID localKey="19-30193863-AACAGCCCCCCG-A" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002059010" DateUpdated="2022-01-15" DateCreated="2022-01-15" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <CitationText>PMID:21981780</CitationText>
          </Citation>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region (PVS1_S). The variant has been reported to be associated with C19orf12 related disorder (ClinVar ID: VCV000031155, PMID:21981780).It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000100, PM2_M). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000707" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001258" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001336" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0007441" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0007354" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002366" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002493" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001031726.3:c.204_214del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615043" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918354</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4924757" SubmissionDate="2022-05-16" DateLastUpdated="2023-03-04" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="GDXSV:226908" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002512937" DateUpdated="2023-03-04" DateCreated="2022-05-21" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 84 amino acids are replaced with 9 different amino acids; This variant is associated with the following publications: (PMID: 23269600, 28347614, 23494994, 24636776, 23436634, 21981780)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19ORF12" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1741742</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001031726.3:c.204_214del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_104_20220504054205</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7183224" SubmissionDate="2023-04-14" DateLastUpdated="2023-05-13" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="NM_001031726.4:c.171_181del11|MedGen:CN043643" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003845016" DateUpdated="2023-05-13" DateCreated="2023-03-26" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31087512</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33607528</ID>
          </Citation>
          <Comment>Variant summary: C19orf12 c.171_181del11/p.Gly58ArgfsX10 (legacy name c.204_214del11/p.Gly69ArgfsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been associated with Neurodegeneration With Brain Iron Accumulation in HGMD. The variant allele was found at a frequency of 7.6e-05 in 249194 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in C19orf12 causing Neurodegeneration With Brain Iron Accumulation (7.6e-05 vs 0.0006). c.171_181del11 has been reported in the literature in multiple individuals affected with Neurodegeneration With Brain Iron Accumulation (Gregory_2019, Sparber_2021, etc). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five ClinVar submitters have submitted clinical-significance assessments for this variant to ClinVar after 2014. All laboratories classified the variant as pathogenic (n=3) or likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001031726.4:c.171_181del11</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043643" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12956415</SubmissionName>
          <SubmissionName>SUB13077516</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2373937" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="242981|MedGen:C2680446" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001208652" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21981780</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23436634</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28641177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30392167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21981780</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23436634</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28641177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30392167</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly69Argfs*10) in the C19orf12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 84 amino acid(s) of the C19orf12 protein. This variant is present in population databases (rs515726204, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with autosomal recessive neurodegeneration with brain iron accumulation or mitochondria protein-associated neurodegeneration (PMID: 21981780, 23436634, 28641177, 30392167). It is commonly reported in individuals of Polish ancestry (PMID: 21981780, 23436634, 28641177, 30392167). ClinVar contains an entry for this variant (Variation ID: 31155). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.30193864_30193874del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2680446" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="278524" SubmissionDate="2021-11-10" DateLastUpdated="2022-10-01" DateCreated="2014-05-31">
        <ClinVarSubmissionID localKey="NM_001031726.3:c.204_214del11|OMIM:614298" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000153732" DateUpdated="2022-10-01" DateCreated="2014-05-31" Type="SCV" Version="4" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21981780</ID>
          </Citation>
          <Comment>Founder variant in Eastern European (Polish) population; Associated with juvenile onset</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001031726.3:c.204_214del11</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280371" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10642765</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>mt-mpan_4-24-2014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8810185" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="3586910|C19orf12-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004735215" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The C19orf12 c.204_214del11 variant is predicted to result in a frameshift and premature protein termination (p.Gly69Argfs*10). This variant has primarily been reported in the homozygous or compound heterozygous states in individuals with autosomal recessive neurodegeneration with brain iron accumulation (see for example, Table 1, Hartig et al. 2011. PubMed ID: 21981780; Table 1, Schulte et al. 2012. PubMed ID: 23436634; Goldman et al. 2013. PubMed ID: 23494994). In these studies heterozygous carriers were reported as unaffected. However, in a single case it has also been associated with autosomal dominant neurodegeneration with brain iron accumulation (Table 1, Sparber et al. 2021. PubMed ID: 33607528). This variant has been classified as pathogenic in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/31155/). Given the evidence, we interpret this variant as pathogenic in the context of autosomal recessive disease, and as a variant of uncertain significance in the context of autosomal dominant disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001031726.3:c.204_214del11</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">C19orf12-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5509071" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-01-21">
        <ClinVarSubmissionID localKey="125985|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002822540" DateUpdated="2024-07-15" DateCreated="2023-01-21" Type="SCV" Version="11" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="A" referenceAllele="AACAGCCCCCCG" start="30193863" stop="30193874" variantLength="12" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4924757" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001336" MappingRef="HP">
        <MedGen CUI="C0027066" Name="Myoclonus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="278524" TraitType="Disease" MappingType="XRef" MappingValue="C3280371" MappingRef="MedGen">
        <MedGen CUI="C3280371" Name="Neurodegeneration with brain iron accumulation 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007354" MappingRef="HP">
        <MedGen CUI="C0002736" Name="Amyotrophic lateral sclerosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001258" MappingRef="HP">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002366" MappingRef="HP">
        <MedGen CUI="C1865412" Name="Abnormal lower motor neuron morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7183224" TraitType="Disease" MappingType="XRef" MappingValue="CN043643" MappingRef="MedGen">
        <MedGen CUI="C2931845" Name="Neurodegeneration with brain iron accumulation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002493" MappingRef="HP">
        <MedGen CUI="C1839042" Name="Upper motor neuron dysfunction" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2373937" TraitType="Disease" MappingType="XRef" MappingValue="C2680446" MappingRef="MedGen">
        <MedGen CUI="C2680446" Name="Hereditary spastic paraplegia 43" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000707" MappingRef="HP">
        <MedGen CUI="C0497552" Name="Abnormality of the nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5509071" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007441" MappingRef="HP">
        <MedGen CUI="C4024877" Name="Hyperpigmented/hypopigmented macules" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8810185" TraitType="Disease" MappingType="Name" MappingValue="C19orf12-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="C19orf12-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032643" TraitType="Disease" MappingType="XRef" MappingValue="615043" MappingRef="OMIM">
        <MedGen CUI="C2680446" Name="Hereditary spastic paraplegia 43" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002018013</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

